"The voice for cancer physicians and their patients in Massachusetts."
The U.S. Food and Drug Administration approved Mvasi (bevacizumab-awwb, Amgen) as a biosimilar to Avastin (bevacizumab, Genentech). Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer. Read full press release.
Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451
Waltham, MA. 02451